Ono Pharmaceutical Co (MEX:4528N) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4528N Ono Pharmaceutical Co Ltd MEX:4528N
89 GF Score
Price MXN341.69
GF Value MXN311.93
! 2 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

MEX:4528N
89GF Score
Ono Pharmaceutical Co Ltd MEX:4528N
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN341.69 is trading 9.5% above its estimated GF Value™ of MXN311.93.

Key valuation signals for MEX:4528N:

  • Interest Received:
  • GF Value™: MXN311.93 vs. price of MXN341.69 (9.5% above fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
89GF Score

Get the complete analysis for MEX:4528N

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN341.69
Price
MXN311.93
GF Value